403,691 Shares in Viemed Healthcare, Inc. $VMD Acquired by Raffles Associates LP

Raffles Associates LP acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 403,691 shares of the company’s stock, valued at approximately $4,602,000. Viemed Healthcare makes up 3.8% of Raffles Associates LP’s investment portfolio, making the stock its 9th largest position.

Several other hedge funds and other institutional investors have also recently bought and sold shares of VMD. Renaissance Technologies LLC boosted its position in Viemed Healthcare by 0.3% during the first quarter. Renaissance Technologies LLC now owns 442,200 shares of the company’s stock worth $4,073,000 after purchasing an additional 1,400 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Viemed Healthcare by 2.2% in the first quarter. Bank of New York Mellon Corp now owns 81,326 shares of the company’s stock valued at $749,000 after purchasing an additional 1,773 shares during the last quarter. Martingale Asset Management L P increased its position in shares of Viemed Healthcare by 6.0% in the fourth quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock valued at $316,000 after buying an additional 2,399 shares in the last quarter. Invesco Ltd. increased its position in shares of Viemed Healthcare by 17.1% in the fourth quarter. Invesco Ltd. now owns 21,773 shares of the company’s stock valued at $162,000 after buying an additional 3,173 shares in the last quarter. Finally, Barclays PLC raised its stake in shares of Viemed Healthcare by 2.7% during the 4th quarter. Barclays PLC now owns 131,759 shares of the company’s stock worth $979,000 after buying an additional 3,480 shares during the last quarter. 74.24% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Wall Street Zen lowered shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Freedom Capital downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Barrington Research initiated coverage on shares of Viemed Healthcare in a research report on Monday. They set an “outperform” rating and a $14.00 target price for the company. Finally, Weiss Ratings cut shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. One equities research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $14.00.

Insiders Place Their Bets

In related news, insider William Frazier sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the transaction, the insider owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. The trade was a 12.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the transaction, the director owned 75,518 shares in the company, valued at approximately $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 20.60% of the stock is owned by company insiders.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $9.01 on Friday. The business’s fifty day moving average price is $10.87 and its two-hundred day moving average price is $9.90. The stock has a market cap of $343.19 million, a PE ratio of 25.03, a price-to-earnings-growth ratio of 2.30 and a beta of 1.10. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13. Viemed Healthcare, Inc. has a one year low of $6.05 and a one year high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%.The company had revenue of $78.10 million during the quarter, compared to analyst estimates of $78.00 million. On average, analysts forecast that Viemed Healthcare, Inc. will post 0.41 EPS for the current fiscal year.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.